• In a medical breakthrough that could reshape the future of HIV treatment, researchers have successfully used CRISPR/Cas9 gene-editing technology to eliminate HIV from human T-cells—and in follow-up lab tests, the virus did not return. This marks a major shift from traditional antiretroviral therapies, which only suppress viral replication but cannot remove the virus embedded in the host's DNA. By directly excising the proviral HIV-1 genome from immune cells, this technique targets the root of the infection—something decades of treatments have struggled to achieve.

    What makes this discovery even more promising is that the edited immune cells were not only HIV-free but also resistant to reinfection. That suggests a future where patients might receive a one-time treatment capable of permanently curing HIV. While human clinical trials are still in early stages and much research remains, the results signal hope for millions living with the virus. If proven safe and effective in broader applications, this could become one of the most transformative moments in medical history.

    #HIVCure #GeneEditing #CRISPR #MedicalBreakthrough #FutureOfMedicine
    In a medical breakthrough that could reshape the future of HIV treatment, researchers have successfully used CRISPR/Cas9 gene-editing technology to eliminate HIV from human T-cells—and in follow-up lab tests, the virus did not return. This marks a major shift from traditional antiretroviral therapies, which only suppress viral replication but cannot remove the virus embedded in the host's DNA. By directly excising the proviral HIV-1 genome from immune cells, this technique targets the root of the infection—something decades of treatments have struggled to achieve. What makes this discovery even more promising is that the edited immune cells were not only HIV-free but also resistant to reinfection. That suggests a future where patients might receive a one-time treatment capable of permanently curing HIV. While human clinical trials are still in early stages and much research remains, the results signal hope for millions living with the virus. If proven safe and effective in broader applications, this could become one of the most transformative moments in medical history. #HIVCure #GeneEditing #CRISPR #MedicalBreakthrough #FutureOfMedicine
    0 التعليقات 0 المشاركات 22كيلو بايت مشاهدة
  • Scientists at the University of Sunderland, led by Dr. Maria Teresa Borrello, have developed two experimental drugs—DR-3 and FDR2—that target the enzyme HDAC6.

    These drugs have shown promise in halting or reversing liver fibrosis, a condition characterized by the accumulation of scar tissue in the liver.

    Research Overview

    The research, published in The FEBS Journal, focuses on the role of HDAC6 in liver fibrosis.

    HDAC6 is involved in regulating inflammation and the activation of hepatic stellate cells, which are responsible for producing collagen and contributing to scar tissue formation.

    By inhibiting HDAC6, the experimental drugs aim to reduce inflammation and prevent the activation of these stellate cells, thereby mitigating fibrosis progression.

    Laboratory Findings

    In laboratory settings, the HDAC6 inhibitors DR-3 and FDR2 demonstrated high selectivity for HDAC6 over other histone deacetylases.

    They effectively reduced markers of hepatic stellate cell activation and fibrogenic gene expression.

    Additionally, these compounds increased acetylation of α-tubulin and suppressed TGF-β1-induced SMAD signaling, which are key pathways in fibrosis development.

    Ex Vivo Human Liver Models

    The efficacy of DR-3 and FDR2 was further validated using human precision-cut liver slices (hPCLS), an ex vivo model that closely mimics human liver tissue.

    Treatment with these inhibitors resulted in reduced fibrogenic protein levels and collagen deposition, indicating their potential to reverse existing fibrosis.

    Importantly, these effects were achieved without significant toxicity to the liver tissue.

    Clinical Implications

    The British Liver Trust has welcomed these findings, highlighting their potential to transform care for the UK's estimated two million liver fibrosis patients, many of whom are diagnosed at advanced stages of the disease.

    While these results are promising, the drugs are still in the experimental phase and have not yet undergone human clinical trials. Nevertheless, they offer a targeted therapeutic approach that could eventually become a lifesaving treatment worldwide.
    Scientists at the University of Sunderland, led by Dr. Maria Teresa Borrello, have developed two experimental drugs—DR-3 and FDR2—that target the enzyme HDAC6. These drugs have shown promise in halting or reversing liver fibrosis, a condition characterized by the accumulation of scar tissue in the liver. Research Overview The research, published in The FEBS Journal, focuses on the role of HDAC6 in liver fibrosis. HDAC6 is involved in regulating inflammation and the activation of hepatic stellate cells, which are responsible for producing collagen and contributing to scar tissue formation. By inhibiting HDAC6, the experimental drugs aim to reduce inflammation and prevent the activation of these stellate cells, thereby mitigating fibrosis progression. Laboratory Findings In laboratory settings, the HDAC6 inhibitors DR-3 and FDR2 demonstrated high selectivity for HDAC6 over other histone deacetylases. They effectively reduced markers of hepatic stellate cell activation and fibrogenic gene expression. Additionally, these compounds increased acetylation of α-tubulin and suppressed TGF-β1-induced SMAD signaling, which are key pathways in fibrosis development. Ex Vivo Human Liver Models The efficacy of DR-3 and FDR2 was further validated using human precision-cut liver slices (hPCLS), an ex vivo model that closely mimics human liver tissue. Treatment with these inhibitors resulted in reduced fibrogenic protein levels and collagen deposition, indicating their potential to reverse existing fibrosis. Importantly, these effects were achieved without significant toxicity to the liver tissue. Clinical Implications The British Liver Trust has welcomed these findings, highlighting their potential to transform care for the UK's estimated two million liver fibrosis patients, many of whom are diagnosed at advanced stages of the disease. While these results are promising, the drugs are still in the experimental phase and have not yet undergone human clinical trials. Nevertheless, they offer a targeted therapeutic approach that could eventually become a lifesaving treatment worldwide.
    0 التعليقات 0 المشاركات 21كيلو بايت مشاهدة
  • Spanish Zarzuela de Mariscos – Catalan Seafood Medley

    A luxurious seafood stew from Catalonia, Zarzuela is made with a medley of shellfish and fish in a saffron-tomato-white wine sauce, often served at special occasions.

    Ingredients (Serves 4):

    * 200g shrimp
    * 200g mussels
    * 200g clams
    * 300g firm white fish (hake, monkfish)
    * 1 onion, chopped
    * 2 garlic cloves, minced
    * 2 tomatoes, peeled and chopped
    * 100ml white wine
    * 1 pinch saffron threads
    * Olive oil, salt, pepper, parsley

    Instructions:

    1. Sauté onion and garlic in olive oil. Add tomatoes and saffron, cook until thickened.
    2. Pour in white wine and simmer.
    3. Add fish, then mussels, clams, and shrimp. Cover and steam until shellfish open and fish is cooked.
    4. Season and garnish with parsley. Serve with toasted bread.

    Catalan Tip:
    For extra richness, blend a paste of almonds and garlic (picada) and stir in before serving.
    Spanish Zarzuela de Mariscos – Catalan Seafood Medley A luxurious seafood stew from Catalonia, Zarzuela is made with a medley of shellfish and fish in a saffron-tomato-white wine sauce, often served at special occasions. Ingredients (Serves 4): * 200g shrimp * 200g mussels * 200g clams * 300g firm white fish (hake, monkfish) * 1 onion, chopped * 2 garlic cloves, minced * 2 tomatoes, peeled and chopped * 100ml white wine * 1 pinch saffron threads * Olive oil, salt, pepper, parsley Instructions: 1. Sauté onion and garlic in olive oil. Add tomatoes and saffron, cook until thickened. 2. Pour in white wine and simmer. 3. Add fish, then mussels, clams, and shrimp. Cover and steam until shellfish open and fish is cooked. 4. Season and garnish with parsley. Serve with toasted bread. Catalan Tip: For extra richness, blend a paste of almonds and garlic (picada) and stir in before serving.
    0 التعليقات 0 المشاركات 21كيلو بايت مشاهدة
  • Japan has just shattered records with an internet speed of 402 terabits per second, using existing fiber optic infrastructure. That’s over 50,000 times faster than most home connections today. Achieved by researchers at Japan’s National Institute of Information and Communications Technology (NICT), this breakthrough used advanced wavelength multiplexing and signal amplification techniques—without the need for exotic or entirely new cabling systems.

    This isn’t just a lab feat; it signals the future of global internet infrastructure. The implications are massive—from ultra-fast cloud computing and real-time 8K streaming to next-gen telemedicine, AI communication, and immersive VR experiences. With bandwidth becoming the backbone of modern civilization, Japan’s achievement could usher in an era where latency is nearly extinct and data moves faster than thought.

    #InternetSpeed #FiberOptics #JapanInnovation #TechBreakthrough
    #FutureOfConnectivity
    Japan has just shattered records with an internet speed of 402 terabits per second, using existing fiber optic infrastructure. That’s over 50,000 times faster than most home connections today. Achieved by researchers at Japan’s National Institute of Information and Communications Technology (NICT), this breakthrough used advanced wavelength multiplexing and signal amplification techniques—without the need for exotic or entirely new cabling systems. This isn’t just a lab feat; it signals the future of global internet infrastructure. The implications are massive—from ultra-fast cloud computing and real-time 8K streaming to next-gen telemedicine, AI communication, and immersive VR experiences. With bandwidth becoming the backbone of modern civilization, Japan’s achievement could usher in an era where latency is nearly extinct and data moves faster than thought. #InternetSpeed #FiberOptics #JapanInnovation #TechBreakthrough #FutureOfConnectivity
    0 التعليقات 0 المشاركات 22كيلو بايت مشاهدة
  • Heads up, stargazers! June 2025 is packed with stunning sights in the night sky — mark these celestial events on your calendar:

    June 10 – The Moon Meets Antares�The nearly full Moon will pass directly in front of the bright red star Antares — visible as a dramatic occultation from Australia, New Zealand, Papua New Guinea, and parts of Indonesia. Elsewhere, they'll appear as a striking close pair in the sky.

    June 11 – Full Strawberry Moon�The final full moon of spring in the Northern Hemisphere rises! Traditionally called the Strawberry Moon, it’s a bright and beautiful lunar event you won't want to miss.

    June 17 – Mars and Regulus Conjunction�Look west after sunset to spot Mars cozying up to Regulus, the brightest star in Leo. They'll appear like a celestial double star — visible from both hemispheres.
    June 19 – Triple Treat in the Morning Sky�A slender crescent Moon joins Saturn and Neptune in a rare predawn alignment. Grab your binoculars or a telescope and look east just before sunrise.

    June 27 – Boötid Meteor Shower Peaks�This slow, gentle meteor shower is unpredictable — sometimes quiet, sometimes bursting with surprise activity. Best viewed after midnight under dark northern skies.

    June 29 – Saturn and Neptune Conjunction�Another beautiful early morning event: Saturn and Neptune will appear close enough to share a telescope view. Catch them before dawn for a planetary double feature!
    Heads up, stargazers! June 2025 is packed with stunning sights in the night sky — mark these celestial events on your calendar: June 10 – The Moon Meets Antares�The nearly full Moon will pass directly in front of the bright red star Antares — visible as a dramatic occultation from Australia, New Zealand, Papua New Guinea, and parts of Indonesia. Elsewhere, they'll appear as a striking close pair in the sky. June 11 – Full Strawberry Moon�The final full moon of spring in the Northern Hemisphere rises! Traditionally called the Strawberry Moon, it’s a bright and beautiful lunar event you won't want to miss. June 17 – Mars and Regulus Conjunction�Look west after sunset to spot Mars cozying up to Regulus, the brightest star in Leo. They'll appear like a celestial double star — visible from both hemispheres. June 19 – Triple Treat in the Morning Sky�A slender crescent Moon joins Saturn and Neptune in a rare predawn alignment. Grab your binoculars or a telescope and look east just before sunrise. June 27 – Boötid Meteor Shower Peaks�This slow, gentle meteor shower is unpredictable — sometimes quiet, sometimes bursting with surprise activity. Best viewed after midnight under dark northern skies. June 29 – Saturn and Neptune Conjunction�Another beautiful early morning event: Saturn and Neptune will appear close enough to share a telescope view. Catch them before dawn for a planetary double feature!
    0 التعليقات 0 المشاركات 21كيلو بايت مشاهدة
الصفحات المعززة